Glass and Glass-Ceramic Technologies to Transform the World

International Journal of Applied Glass Science

Volumn 2, Issue 3, 2011, Pages 162-176

  Hench, Larry L ^a,b,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN CERAMIC SOCIETY; BIOACTIVE MATERIAL; BREAKTHROUGH TECHNOLOGY; HEALTHCARE SECTORS; INNOVATIVE TECHNOLOGY; PERSONAL PERSPECTIVE; PREVENTATIVE MEDICINES; TECHNICAL FEASIBILITY;

CERAMIC MATERIALS; DISEASE CONTROL; GLASS; HEALTH CARE; SECONDARY BATTERIES; STEM CELLS; TISSUE; TISSUE REGENERATION;

TECHNOLOGY;

EID: 84877723774     PISSN: 20411286     EISSN: 20411294     Source Type: Journal    
DOI: 10.1111/j.2041-1294.2011.00056.x     Document Type: Article

References (93)

1. 2 Monoliths Containing Transition Metals and Their Production, " U.S. Patent 4851373 (dated 07/25), US Patent and Trademark Office, Washington, D.C., 1989.
2. L. L. Hench and J. K. West, "The Sol-Gel Process, " Chem. Rev., 90 33 (1990).
3. L. L. Hench and W. Vasconcelos, "Gel-Silica Science, " Annu. Rev. Mater. Sci., 20 269-298 (1990).
4. L. L. Hench and J. L. Noguès, "Sol-Gel Processing of Net Shape Silica Optics, " Sol-Gel Optics, ed. L. C. Klein Kluwer Academic Publishers, Norwell, MA, 59-81, 1994.
5. L. L. Hench, Sol-Gel Silica: Processing, Properties and Technology Transfer, Noyes Publications, Westwood, NJ, 1998.
6. B. E. Conway, Electrochemical Supercapacitors: Scientific Fundamentals and Technological Applications, Kluwer Academic/Plenum Publishing, New York, 1999.
7. J. Huang, B. G. Sumpter, and V. Meunier, "A Universal Model for Nanoporous Carbon Supercapacitors Applicable to Diverse Pore Regimes, Carbon Materials, and Electrolytes, " Chem. Eur. J, 14 6614-6626 (2008).
8. J. Huang, B. G. Sumpter, and V. Meunier, "Nanoporous Carbon Supercapacitors: From Double Layer, to Double Cylinder, to Wire in Cylinder, " Angew. Chem., 120 3440 (2008).
9. J. Chmiola, G. Yushin, Y. Gogotsi, C. Portet, P. Simon, and P. L. Taberna, "Anomalous Increase in Carbon Capacitance at Pore Sizes Less Than 1 Nanometer, " Science, 313 1760-1763 (2006).
10. L. L. Hench and I. Thompson, "Twenty-First Century Challenges for Biomaterials, " J. R. Soc. Interface, 7 S379-S391 (2010).
11. L. L. Hench, "Bioceramics: From Concept to Clinic, " J. Am. Ceram. Soc., 74 [7] 1487-1510 (1991).
12. L. L. Hench and J. Wilson, eds. Clinical Performance of Skeletal Prostheses, Chapman and Hall, Ltd., London, 1996.
13. L. L. Hench and J. M. Polak, "Third-Generation Biomedical Materials, " Science, 295 1014-1017 (2002).
14. E. S. Place, N. D. Evans, and M. M. Stevens, "Complexity in Biomaterials and Other Challenges in the Translation of Tissue Engineering, " Nat. Mater., 8 457-470 (2009).
15. L. L. Hench, R. J. Splinter, W. C. Allen, and T. K. Greenlee Jr., "Bonding Mechanisms at the Interface of Ceramic Prosthetic Materials, " J. Biomed. Mater. Res., 2 [1] 117-141 (1971).
16. L. L. Hench, J. W. Hench, and D. C. Greenspan, "Bioglass: A Short History and Bibliography, " J. Aust. Ceram. Soc., 40 [1] 1-42 (2004).
17. J. Wilson and S. B. Low, "Bioactive Ceramics for Periodontal Treatment: Comparative Studies in the Patus Monkey, " J. Appl. Biomater., 3 123-169 (1992).
18. ® 45S5 Stimulates Osteoblast Turnover and Enhances Bone Formation In Vitro: Implications and Applications for Bone Tissue Engineering, " Calcif. Tissue Int., 67 321-329 (2000).
19. L. L. Hench, J. M. Polak, I. D. Xynos, and L. D. K. Buttery, "Bioactive Materials to Control Cell Cycle, " Mat. Res. Innovat., 3 313-323 (2000).
20. I. D. Xynos, A. J. Edgar, L. D. Buttery, L. L. Hench, and J. M. Polak, "Ionic Dissolution Products of Bioactive Glass Increase Proliferation of Human Osteoblasts and Induce Insulin-Like Growth Factor II mRNA Expression and Protein Synthesis, " Biochem. Biophys. Res. Comm., 276 461-465 (2000).
21. ® 45S5 Dissolution, " J. Biomed. Mater. Res., 55 151-157 (2001).
22. L. L. Hench, et al., "Gene Activating Glasses, " J. Inorg. Mater., 17 897-909 (2002).
23. L. L. Hench, "Glass and Genes: The 2001 W. E. S. Turner Memorial Lecture, " Glass Technol., 44 1-10 (2003).
24. J. E. Gough, J. R. Jones, and L. L. Hench, "Nodule Formation and Mineralisation of Human Primary Osteoblasts Cultured on a Porous Bioactive Glass Scaffold, " Biomaterials, 25 2039-2046 (2004).
25. J. R. Jones, O. Tsigkou, E. E. Coates, M. M. Stevens, J. M. Polak, and L. L. Hench, "Extracellular Matrix Formation and Mineralization of on a Phosphate-Free Porous Bioactive Glass Scaffold Using Primary Human Osteoblast (HOB) Cells, " Biomaterials, 28 1653-1663 (2007).
26. I. Christodoulou, L. D. K. Buttery, P. Saravanapavan, G. P. Tai, L. L. Hench, and J. M. Polak, "Characterization of Human Foetal Osteoblasts by Microarray Analysis following Stimulation with 58S Bioactive Gel-Glass Ionic Dissolution Products, " J. Biomed. Mater. Res. B Appl. Biomater., 77B 431-446 (2005).
27. R. C. Bielby, I. S. Christodoulou, R. S. Pryce, W. J. P. Radford, L. L. Hench, and J. M. Polak, "Time- and Concentration-Dependent Effects of Dissolution Products of 58S Sol-Gel Bioactive Glass on Proliferation and Differentiation of Murine and Human Osteoblasts, " Tissue Eng., 10 1018-1026 (2004).
28. R. C. Bielby, R. S. Pryce, L. L. Hench, and J. M. Polak, "Enhanced Derivation of Osteogenic Cells from Murine Embryonic Stem Cells after Treatment with Ionic Dissolution Products of 58S Bioactive Sol-Gel Glass, " Tissue Eng., 11 479-488 (2004).
29. I. Christodoulou, L. D. K. Buttery, P. Saravanapavan, G. P. Tai, L. L. Hench, and J. M. Polak, "Dose- and Time-Dependent Effect of Bioactive Gel-Glass Ionic-Dissolution Products on Human Fetal Osteoblast-Specific Gene Expression, " J. Biomed. Mater. Res. B Appl. Biomater., 74B 529-537 (2005).
30. ® Repeat Dosage on Mineralization of Embryonic Bone In Vitro, " Key Eng. Mater., 192-195 575-588 (2001).
31. J. R. Jones and L. L. Hench, "Factors Affecting the Structure and Properties of Bioactive Foam Scaffolds for Tissue Engineering, " J. Biomed. Mater. Res. B Appl. Biomater., 68B 36-44 (2004).
32. J. R. Jones, L. M. Ehrenfried, and L. L. Hench, "Optimising Bioactive Glass Scaffolds for Bone Tissue Engineering, " Biomaterials, 27 964-973 (2006).
33. J. R. Jones, P. D. Lee, and L. L. Hench, "Hierarchical Porous Materials for Tissue Engineering, " Philos. Trans. R. Soc. A, 364 263-281 (2006).
34. R. C. Atwood, J. R. Jones, P. D. Lee, and L. L. Hench, "Analysis of Pore Interconnectivity in Bioactive Glass Foams Using X-Ray Microtomography, " Scr. Mater., 51 1029-1033 (2004).
35. M. M. Pereira, J. R. Jones, and L. L. Hench, "Bioactive Glass and Hybrid Scaffolds Prepared by Sol-Gel Method for Bone Tissue Engineering, " Adv. Appl. Ceram., 104 35-42 (2005).
36. M. M. Pereira, S. N. Nazhat, J. R. Jones, and L. L. Hench, "Mechanical Behavior of Bioactive Glass-Polyvinyl Alcohol Hybrid Foams Obtained by the Sol-Gel Process, " Bioceramics, 17 757-760 (2005).
37. C. A. Shapoff, D. C. Alexander, and A. E. Clark, "Clinical Use of a Bioactive Glass Particulate in the Treatment of Human Osseous Defects, " Compend. Contin. Educ. Dent., 18 [4] 352-354 (1997).
38. T. B. Lovelace, J. T. Mellonig, R. M. Meffert, A. A. Jones, P. V. Nummikoski, and D. L. Cochran, "Clinical Evaluation of Bioactive Glass in the Treatment of Periodontal Osseous Defects in Humans, " J. Periodontol., 69 1027-1035 (1998).
39. ® Implants, " Bioceramics 7, eds., H. Andersson, R-P. Happonen, and A. Yli-Urpo Butterworth-Heinemann, Oxford, England, 415-422, 1994.
40. J. S. Park, et al., "Effects of Pre-treatment Clinical Parameters on Bioactive Glass Implantation in Intrabony Periodontal Defects, " J. Periodontal., 72 [6] 730-740 (2001).
41. K. Aitasalo, I. Kinnunen, J. Palmgren, and M. Varpula, "Repair of Orbital Floor Fractures with Bioactive Glass Implants, " J. Oral Maxillofac. Surg., 59 [12] 1390-1395 (2001).
42. R. A. Yukna, G. H. Evans, M. B. Aichelmann-Reidy, and E. T. Mayer, "Clinical Comparison of Bioactive Glass Bone Replacement Graft Material and Expanded Polytetrafluoroethylene Barrier Membrane In Treating Human Mandibular Molar Class II Furcations, " J. Periodontol., 72 [2] 125-133 (2001).
43. R. Mengel, M. Soffner, and L. Flores-de-Jacoby, "Bioabsorbable Membrane and Bioactive Glass In The Treatment of Intrabony Defects In Patients With Generalized Aggressive Periodontitis: Results of A 12-Month Clinical and Radiological Study, " J. Periodontol., 74 [6], 899-908 (2003).
44. B. E. Ilharreborde, et al., "Bioactive Glass as a Bone Substitute for Spinal Fusion in Adolescent Idiopathic Scoliosis: A Comparative Study with Iliac Crest Autograft, " J. Pediatr. Orthop., 28 347-351 (2008).
45. E. Ameri, H. Behtash, B. Mobini, F. Omidi-Kashani, and M. Nojomi, "Bioactive Glass versus Autogenous Iliac Crest Bone Graft in Adolescent Idiopathic Scoliosis Surgery, " Acta Med. Iran., 47 [1] 41-45 (2009).
46. L. L. Hench, D. E. Day, W. Hohland, and V. M. Rheinberger, "Glass and Medicine, " Int. J. Appl. Glass Sci., 1 [1] 104-117 (2010).
47. R. Salem and K. G. Thurston, "Radioembolization with Yttrium-90 Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies, Part 3: Comprehensive Literature Review and Future Direction, " J. Vasc. Interv. Radiol., 17 1571-1594 (2006).
48. H. B. El-Serag, A. C. Mason, and C. Key, "Trends in Survival of Patients with Hepatocellular Carcinoma Between 1977 and 1996 in the United States, " Hepatology, 33 62-65 (2001).
49. M. J. Hyatt and D. E. Day, "Glass Properties in the Yttria-Alumina-Silica System, " J. Am. Ceram. Soc., 70 [10] C-283-C-287 (1987).
50. 2 Glasses for the in vivo Delivery of Beta Radiation, " J. Biomed. Mater. Res., 27 1301-1308 (1993).
51. K. Okuda, T. Ohtsuki, and H. Obata, et al., "Natural History of Hepatocellular Carcinoma and Prognosis in Relation to Treatment: Study of 850 Patients, " Cancer, 56 918-928 (1985).
52. A. L. Keppke, R. Salem, andD. Reddy, et al., "Imaging of Hepatocellular Carcinoma After Treatment with Yttrium-90 Microspheres, " Am. J. Roentgenol., 188 768-775 (2007).
53. TM) Treatment of Unresectable Hepatocellular Carcinoma: Downstaging to Resection, RFA and Bridge to Transplantation, " J. Surg. Oncol., 94 [7] 572-586 (2006).
54. R. C. Gaba, R. J. Lewandowski, and L. Kulik, et al., "Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization, " Ann. Surg. Oncol., 16 1587-1596 (2009).
55. J. E. White and D. E. Day, "Rare Earth Aluminosilicate Glasses for In Vivo Radiation Delivery, " Key Eng. Mater., 94-95 181-208 (1994).
56. G. C. Wicks, L. K. Heung, and R. F. Schumacher, "Microspheres and Microworlds, " Am. Ceram. Bull., 87 [6] 23-27 (2010).
57. L. K. Heung, R. F. Schumacher, and G. C. Wicks, "Hollow Porous Wall Microspheres", U.S. Patent Filed 10/21/05, PCT filed 10/17/06.
58. A. A. Gorustovich, L. A. H. Durand, and A. R. Boccaccini, "Bioactive Glasses and Angiogenesis, " New Materials and Technologies for Healthcare, Chapter 6, eds., L. L. Hench, J. R. Jones, and M. B. Fenn Imperial College Press, London/Singapore, 2011.
59. ®-Filled Polylactide Foams, " J. Biomed. Mater. Res., 66A 335-346 (2003).
60. ® Composites with Tailored Pore Structure for Tissue Engineering Applications, " Comp. Sci. Technol., 63 2417-2429 (2003).
61. R. M. Day, et al., "Assessment of Polyglycolic Acid Mesh and Bioactive Glass for Soft-Tissue Engineering Scaffolds, " Biomaterials, 25 5857-5866 (2004).
62. S. Verrier, J. J. Blaker, V. Maquet, L. L. Hench, and A. R. Boccaccini, "PDLLA/Bioglass Composites for Soft-Tissue and Hard-Tissue Engineering: An In Vitro Cell Biology Assessment, " Biomaterials, 25 3013-3021 (2004).
63. L. L. Hench, A. R. Boccaccini, R. M. Day, and S. M. Gabe, "Third-Generation Gene-Activating Biomaterials, " Mater. Sci. Forum, 426-432 179-184 (2003).
64. R. M. Day, "Bioactive Glass Stimulates the Secretion of Angiogenic Growth Factors and Angiogenesis In Vitro, " Tissue Eng., 11 768-777 (2005).
65. R. M. Day, V. Maquet, A. R. Boccaccini, R. Jerome, and A. Forbes, "In Vitro and In Vivo Analysis of Macro-Porous Bio-Degradable Poly(D, L-Lactide-Co-Glycolide) Scaffolds Containing Bioactive Glass, " J. Biomed. Res., 75A 778-787 (2005).
66. A. Leu and J. K. Leach, "Proangiogenic Potential of a Collagen/Bioactive Glass Substrate, " Pharm. Res., 25 1222 (2008).
67. A. A. Gorustovich, J. A. Roether, and A. R. Boccaccini, "Effect of Bioactive Glasses on Angiogenesis: A Review of In Vitro and In Vivo Evidences, " Tissue Eng. B Rev., 16 [2] 199-207 (2010).
68. S. R. Moosvi and R. M. Day, "Bioactive Glass Modulation of Intestinal Epithelial Cell Restitution, " Acta Biomater., 5 76-83 (2009).
69. L. L. Hench, J. R. Jones, and M. B. Fenn, New Materials and Technologies for Healthcare, Chapters 18-23, Imperial College Press, London/Singapore, 2011.
70. J. Pano, Stem Cell Research: Medical Applications and Ethical Controversy, Checkmark Books, New York, NY, 2006.
71. O. Z. Fisher, A. Khademhosseini, R. Langer, and N. A. Peppas, "Bioinspired Materials for Controlling Stem Cell Fate, " Acc. Chem. Res., 43 [3] 419-428 (2010).
72. S. F. Badylak, D. F. Freytes, and T. W. Gilbert, "Extracellular Matrix as a Biological Scaffold Material: Structure and Function, " Acta Biomater., 5, 1-13 (2009).
73. J. Polak and L. Hench, "Gene Therapy Progress and Prospects: Tissue Engineering, " Gene Ther., 12 1725-1733 (2005).
74. Z. W. Hall, D. Kahler, and M. Manganiello, et al., "Breaking Ground on Translational Stem Cell Research, " Ann. N.Y. Acad. Sci., 1189, E1-E15 (2010).
75. J. Polak, S. Mantalaris, and S. E. Harding, Advances in Tissue Engineering, Imperial College Press, London, U.K., 2008.
76. Y-S. Hwang, et al., "The Use of Murine Embryonic Stem Cells, Alginate Encapsulation, and Rotary Microgravity Bioreactor in Bone Tissue Engineering, " Biomaterials, 1-9 (2008).
77. O. Tsigkou, I. Pomerantseva, and J. A. Spencer, et al., "Engineered Vascularized Bone Grafts, " Proc. Natl Acad. Sci., 107 [8] 3311-3316 (2010).
78. R. Scott, "NovaMin Technology, " J. Clin. Dent., 21 [Spec Iss] 59-61 (2010).
79. D. C. Greenspan, "NovaMin and Tooth Sensitivity-An Overview, " J. Clin. Dent., 21 [Spec. Iss.] 61-65 (2010).
80. A. Burwell, D. Jennings, D. Muscle, and D. C. Greenspan, "NovaMin and Dentinal Hypersensitivity-In Vitro Evidence of Efficacy, " J. Clin. Dent., 21 [Spec. Iss.] 66-71 (2010).
81. G. LaTorre and D. C. Greenspan, "The Role of Ionic Release from NovaMin (Calcium Sodium Phosphosilicate) in Tubule Occlusion: An Exploratory Study using Radio-Labeled Isotopes, " J. Clin. Dent., 21 [Spec. Iss.] 72-76 (2010).
82. L. Litkowski and D. C. Greenspan, "A Clinical Study of the Effect of Calcium Sodium Phosphosilicate on Dentin Hypersensitivity-Proof of Principle, " J. Clin. Dent., 21 [Spec. Iss.] 77-81 (2010).
83. S. Salian, S. Thakur, S. Kulkarni, and G. LaTorre, "A Randomized Controlled Clinical Study Evaluating the Efficacy of Two Desensitizing Dentifrices, " J. Clin. Dent., 21 [Spec. Iss.] 82-87 (2010).
84. N. Sharma, S. Roy, A. Kakar, D. C. Greenspan, and R. Scott, "A Clinical Study Comparing Oral Formulations Containing 7.5% Calcium Phosphosilicate (NovaMin), 5% Potassium Nitrate and 0.4% Stannous Fluoride for the Management of Dentin Hypersensitivity, " J. Clin. Dent., 21 [Spec. Iss.] 88-92 (2010).
85. A. Hoppe, N. S. Güldal, and A. R. Boccaccini, "A Review of the Biological Response to Ionic Dissolution Products from Bioactive Glasses and Glass-Ceramics, " Biomaterials, 32 2757-2774 (2011).
86. M. N. Rahaman, et al., "Bioactive Glass in Tissue Engineering, " Acta Biomater., 7 2355-2373 (2011).
87. F. Baino and C. Vitale-Brovarone, "Three-Dimensional Glass-Derived Scaffolds for Bone Tissue Engineering: Current Trends and Forecasts for the Future, " J. Biomed. Mater. Res. A, 97A 514-535 (2011).
88. Z. Hong, R. L. Reis, and J. F. Mano "Preparation and In vitro Characterization of Scaffolds of Poly (L-lactic acid) Containing Bioactive Glass Ceramic Nanoparticles, " Acta Biomater, 4, 1297-1306 (2008).
89. J. R. Jones, "Hierarchical Porous Scaffolds for Bone Tissue Enginering, " New Materials and Technologies for Healthcare, Chapter 9, eds., L. L. Hench, J. R. Jones, and M. B. Fenn Imperial College Press, London, 2011.
90. P. Wray, "Cotton Candy that Heals?, " Bull. Am. Ceram. Soc., 90 [3] 29-33 (2011).
91. H. Keshaw, A. Forbes, and R. M. Day, "Release of Angiogenic Growth Factors from Cells Encapsulated in Alginate Beads with Bioactive Glass, " Biomaterials, 26 4171-4179 (2005).
92. H. Keshaw, G. Georgiou, and J. J. Blaker, et al., "Assessment of polymer/bioactive glass-composite micro-porous spheres for tissue regeneration applications, " Tissue Eng. A, 15 1451-1461 (2009).
93. L. L. Hench, "Bioceramics, " J. Am. Ceram. Soc., 81 [7] 1705-1728 (1998).